Equity Gap led the seed financing for the Edinburgh based manufacturer of custom fit respirators, with backing from Scottish Enterprise, Old College Capital, and Apollo Informal Investment.
"We realised that by combining modern 3D imaging with 3D-printed soft materials, we could create bespoke, perfectly fitted masks that conform to the unique contours of each face. In our first comparative trial, our masks proved more comfortable than standard disposable alternatives. Since then, we’ve refined our design dramatically yet we’ve remained true to our original mission: to create the most comfortable, personalised respiratory masks possible, suited for every face. We believe the days of painful, pressure-inducing masks are finally over."
SFC Capital backed the wearable tech start-up to fund product development ahead of a Kickstarter launch.
"We knew getting funding for a consumer hardware start-up was incredibly difficult, but when we placed our modular watch in front of SFC Capital, everything clicked. They assembled the components like LEGO, instantly realising the potential. By the end of the meeting, we had our investment interest."
The Series A round was led by IW Capital and will fund sales growth and product development.
"IW Capital are thrilled to announce our investment into Strolll. Strolll are transforming the physiotherapy and neurorehabilitation markets and have already helped a significant number of people with debilitating neurological disorders to live better lives. The potential impact of their software is huge and we’re proud to be backing this cutting-edge business as it addresses key healthcare needs."
Redalpine led the pre-seed round to help the startup bring its wearable hormone sensors to market and expand its team.
"We did it for blood pressure and will do it again for hormones. Continuous hormone measurement is one of the holy grails of diagnostics, and as fundamental science transitions to engineering, we couldn’t be more excited to back Level Zero Health in their mission to transform hormone tracking with their novel biosensor – paving the way for a new era of personalized health management."
The funding was led by Mercia Ventures and the North East Venture Fund to help bring the non-invasive health sensor to market.
"A build-up of lactic acid causes muscles to seize up and athletes to suddenly ‘hit a wall’, but it’s hard for them to know when this will happen without measuring lactate levels. Fingerprick tests are uncomfortable, fiddly and not always accurate. Our device will overcome these problems and provide continuous monitoring, rather than a one-off measurement. This latest funding, together with our partnership with a major global chip manufacturer, will enable us to bring it to market."
.png)
